Product Images Tikosyn

This is a description of a medication containing lofetilide and tikosyn, manufactured by Pfizer. The lot number is N04369, and it is a 0.5mg capsule. The NDC is 6918958201, and it was received by Avera McKennan hospital in Sioux Falls, South Dakota on 03/28/2017. The hospital's lot number is APF16C28-U.*

This appears to be a table displaying dosages and p-values for a certain drug (possibly named Dofetifde) in relation to a placebo. The dosages listed are 125 BID, 250 BID, and 500 BID. The p-values for each dosage are also shown for a "Log Rank Test" in relation to the placebo. It is unclear what the "T T T" and "o 3 3" represent. The table includes a time frame of "Time (Months)" but there is not enough information to determine what the time frame refers to.*

This appears to be a table showing different doses of a medication called Dofetilide and their corresponding p-values when compared to a placebo using a Log Rank Test. The doses listed are 500mcg, 250mcg, and 125mcg to be taken twice a day (BID). The table also shows the p-values for each dose, with the 500mcg and 250mcg doses having p-values of 0.001 and the 125mcg dose having a p-value of 0.006. The data in the table may be related to a clinical trial or study measuring the effectiveness of Dofetilide over a period of time.*

This is a medical text with instructions for the use of dofetilide, a medication used to treat heart arrhythmias. The text provides guidance on the administration of the drug, including dosing based on creatinine clearance, monitoring for changes in QT interval, and adjusting or discontinuing the drug as necessary. The use of dofetilide should be avoided in patients with low creatinine clearance and should be closely monitored for adverse effects on QT interval.*

This is a brief description of a product's distribution information. The product is distributed by Pfizer Labs, which is a division of Pfizer Inc. The location of Pfizer Inc is mentioned as NY, NY 10017.*